European Markets Eye Soft Open as LVMH Posts Mixed Q3 Results and AstraZeneca Teases Growth Catalysts
Newsquawk ·
European stock markets are projected to open slightly lower on October 13, 2026. In corporate updates, AstraZeneca gained 0.7 percent after informing investors that it anticipates multiple high-value biopharmaceutical and oncology catalysts over the coming 12 to 18 months. STMicroelectronics fell 2.2 percent following the proposal and acceptance to reappoint Jean-Marc Chery as President and CEO. On the earnings front, LVMH dipped 0.3 percent as its third-quarter 2026 revenue reached EUR 18.5 billion, edging past the estimated EUR 18.47 billion. However, Fashion and Leather Goods sales dropped 5 percent, missing expectations of a 1.57 percent decline. The CFO noted that Q3 faced macro-driven challenges in China and ongoing Middle East headwinds, adding that short-term cost-cutting will not boost sales. Publicis Groupe lost 0.7 percent after reporting Q3 net revenue of EUR 3.81 billion, beating the EUR 3.75 billion consensus, and reaffirmed its full-year 2026 guidance. Meanwhile, Givaudan advanced 3.5 percent after posting its Q3 revenue figures.
AI 시장 분석
European stock markets on the 13th are expected to open mixed as LVMH's Q3 revenue slightly beat expectations at 18.5 billion euros, though its core fashion and leather division slumped 5% with weak performance. AstraZeneca rose after announcing expectations for major biotech and oncology catalysts within the next 12 to 18 months. Investors need to pay attention to the short-term blows that macroeconomic headwinds in China and the situation in the Middle East are inflicting on the luxury and consumer goods sectors.
상승 영향
- Biotech — Investment sentiment improved as AstraZeneca presented multiple high-value biopharmaceutical and oncology catalysts for the next 12 to 18 months.
하락 영향
- Consumer Goods — LVMH's Q3 fashion and leather goods revenue dropped 5% below expectations, and earnings pressure intensified due to China's macroeconomic slump and Middle East risks.
DYAX 전담 분석
LVMH's Q3 fashion and leather goods revenue fell 5%, significantly missing expectations (-1.57%), applying downward pressure across the luxury sector. The macroeconomic slump in China and Middle East risks were pointed out as the main drivers of the worsened earnings, and the CFO's remark that revenue recovery is difficult through short-term cost cuts dampened investor sentiment.
Future recovery in China's consumer economy and the mitigation of Middle Eastern geopolitical risks will serve as key indicators for a rebound in luxury stock prices. On the other hand, the biotech and healthcare sector is projected to maintain differentiated strength based on expectations for AstraZeneca's pipeline.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 56% · Bearish (Short) 44%
516 participants
Related News
- Netflix's Regions Abroad Are All Growing Faster Than Its Home Market. I Don't Think That Makes the Stock a Bargain.
- Market Focuses on the Factors Driving Greencore Stock Surge Today
- Why Did Whitbread Share Prices Surge Today?
- Monte dei Paschi Rejects Intesa Sanpaolo's Revised Bid as Inadequate
- Why Did Greencore Shares Surge Today?
- SK Hynix and Samsung Plunge on Broadcom AI Financing Warning
